Blood protein coating of gold nanoparticles as potential tool for organ targeting
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Polymer Surface Interaction Studies · Gold and Silver Nanoparticles Synthesis and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (53)
Show source-provided references
1. Targeting the insulin receptor: nanoparticles for drug delivery across the blood-brain barrier (BBB)10.3109/10611861003734001 ↗
2. Blood-brain barrier drug targeting: the future of brain drug development10.1124/mi.3.2.90 ↗
3. Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier10.1080/10611860290031877 ↗
4. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts10.1073/pnas.0805135105 ↗
5. Modeling the time evolution of the nanoparticle-protein corona in a body fluid10.1371/journal.pone.0010949 ↗
6. Time evolution of the nanoparticle protein corona10.1021/nn901372t ↗
7. Identifying new therapeutic targets via modulation of protein Corona formation by engineered nanoparticles10.1371/journal.pone.0033650 ↗
8. Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles10.1021/ja107583h ↗
9. Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: a comprehensive quantitative proteomic analysis10.1021/nn201950e ↗
10. The evolution of the protein corona around nanoparticles: a test study10.1021/nn202458g ↗
11. Active targeting schemes for nanoparticle systems in cancer therapeutics10.1016/j.addr.2008.08.005 ↗
12. Protein corona formation for nanomaterials and proteins of a similar size: hard or soft corona?10.1039/c2nr33611a ↗
13. Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles10.1016/j.nano.2008.08.001 ↗
14. Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy10.1016/j.addr.2009.03.009 ↗
15. Biodistribution of PEG-modified gold nanoparticles following intratracheal instillation and intravenous injection10.1016/j.biomaterials.2010.05.009 ↗
16. Serum protein identification and quantification of the corona of 5, 15 and 80 nm gold nanoparticles10.1088/0957-4484/24/26/265103 ↗
17. The role of albumin in critical illness10.1093/bja/85.4.599 ↗
18. Identification of albumin-binding proteins in capillary endothelial cells10.1083/jcb.107.1.231 ↗
19. Functionalized gold nanoparticles: a detailed in vivo multimodal microscopic brain distribution study10.1039/c0nr00345j ↗
20. Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration10.1016/j.ejpb.2010.12.029 ↗
21. Biodistribution of 1.4- and 18-nm gold particles in rats10.1002/smll.200800922 ↗
22. Size and surface charge of gold nanoparticles determine absorption across intestinal barriers and accumulation in secondary target organs after oral administration10.3109/17435390.2011.552811 ↗
23. The LDL-receptor-related protein, LRP, is an apolipoprotein E-binding protein10.1038/341162a0 ↗
24. Structure of the LDL receptor extracellular domain at endosomal pH10.1126/science.1078124 ↗
25. Recent advances in physiological lipoprotein metabolism
26. VLDL receptor mediates the uptake of human chylomicron remnants in vitro10.1016/S0022-2275(20)39116-1 ↗
27. A study of the nucleation and growth processes in the synthesis of colloidal gold10.1039/df9511100055 ↗
28. A novel class of potential prion drugs: preliminary in vitro and in vivo data for multilayer coated gold nanoparticles10.1039/c0nr00551g ↗
29. Synthesis and multidisciplinary characterization of polyelectrolyte multilayer-coated nanogold with improved stability toward aggregation10.1007/s00396-010-2343-2 ↗
30. Expression of AMPA and NMDA receptor subunits in the cervical spinal cord of wobbler mice10.1186/1471-2202-7-71 ↗
31. Nanoparticles in the lung10.1038/nbt.1735 ↗
32. Das Blutvolumen einiger Rattenorgane und ihre Restblutmenge nach Entbluten bzw. Durchspuelung. Bestimmung mit P32-markierten Erythrocyten10.1007/BF00246232 ↗
33. Conformation changes of albumin in its interaction with physiologically active compounds as studied by quasi-elastic light scattering spectroscopy and ultrasonic method10.1016/S0039-9140(00)00454-9 ↗
34. Ionic binding, net charge, and Donnan effect of human serum albumin as a function of pH10.1093/clinchem/39.1.48 ↗
35. Probing the limits of aptamer affinity with a microfluidic SELEX platform10.1371/journal.pone.0027051 ↗
36. Apolipoprotein E structure: insights into function10.1016/j.tibs.2006.06.008 ↗
37. Effect of surface coating on the biodistribution profile of gold nanoparticles in the rat10.1016/j.ejpb.2011.09.005 ↗
38. Significant effect of size on the in vivo biodistribution of gold composite nanodevices in mouse tumor models10.1016/j.nano.2007.09.001 ↗
39. Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size10.1016/j.colsurfb.2008.07.004 ↗
40. A quantitative fluorescence study of protein monolayer formation on colloidal nanoparticles10.1038/nnano.2009.195 ↗
41. What the cell “sees” in bionanoscience10.1021/ja910675v ↗
42. Challenges in drug delivery to the brain: nature is against us10.1016/j.jconrel.2012.04.044 ↗
43. Mechanisms linking apolipoprotein E isoforms with cardiovascular and neurological diseases10.1097/MOL.0b013e32833af368 ↗
44. Cationic bovine serum albumin based self-assembled nanoparticles as siRNA delivery vector for treating lung metastatic cancer
45. Dual-function theranostic nanoparticles for drug delivery and medical imaging contrast: perspectives and challenges for use in lung diseases10.1007/s13346-013-0132-4 ↗
46. Detection of the presence of gold nanoparticles in organs by transmission electron microscopy10.3390/ma3094681 ↗
47. Biodistribution of gold nanoparticles and gene expression changes in the liver and spleen after intravenous administration in rats10.1016/j.biomaterials.2009.11.079 ↗
48. Particle size-dependent organ distribution of gold nanoparticles after intravenous administration10.1016/j.biomaterials.2007.12.037 ↗
49. A risk-based bioanalytical strategy for the assessment of antibody immune responses against biological drugs10.1038/nbt1303 ↗
50. Heat denaturation, a simple method to improve the immunotherapeutic potential of allergens10.1002/eji.200535076 ↗
51. Size-dependent denaturing kinetics of bovine serum albumin adsorbed onto gold nanospheres10.1140/epje/i2007-10342-9 ↗
52. Preformed albumin corona, a protective coating for nanoparticles based drug delivery system10.1016/j.biomaterials.2013.07.102 ↗
53. Mouse very-low-density-lipoprotein receptor (VLDLR) cDNA cloning, tissue-specific expression and evolutionary relationship with the low-density-lipoprotein receptor10.1111/j.1432-1033.1994.00975.x ↗